Melanoma choroid is a type of cancer that affects the eyes. It's a rare form of eye cancer that usually starts in the thin layer of tissue at the back of the eye, known as the choroid. This type of cancer is most commonly seen in children and young adults, although it can affect any age group. It's important to know about melanoma choroid because early detection is critical for its successful treatment. While there is no one-size-fits-all approach to treatment, understanding risk factors, signs, and symptoms can help increase your chances for a full recovery. In this article, we'll go over everything you need to know about melanoma choroid; from causes and symptoms to potential treatments and more.
Melanoma of the choroid is a rare form of cancer that begins in the choroid, the layer of blood vessels and pigmented cells between the retina and sclera (white part of the eye). The choroid supplies oxygen and nutrients to the retina, and helps to protect it from light.
Most melanomas of the choroid are found in people over age 50. The cause is unknown, but it is believed to be related to exposure to ultraviolet (UV) light. Melanoma of the choroid can occur in any race, but is more common in people with light-colored skin, blue or green eyes, and blond or red hair.
· A change in the color or size of a mole on the body
· A new mole on the body
· A change in the color of the iris
· blurred vision
· floaters (spots in your vision)
· partial or complete loss of vision
There are several potential causes of melanoma choroid, including exposure to ultraviolet (UV) radiation from the sun or other sources, family history of the disease, and certain genetic mutations.
Exposure to UV radiation is the most well-established risk factor for melanoma choroid. The eye is very sensitive to UV rays, and even brief exposure can damage the DNA of cells in the eye. This damage can lead to the development of cancerous tumors.
People with a family history of melanoma choroid are at increased risk for developing the disease themselves. This may be due to shared genetic factors that make some people more susceptible to developing cancer after exposure to UV radiation.
Certain genetic mutations can also increase the risk of developing melanoma choroid. These mutations can be inherited or acquired during a person's lifetime. One example of an inherited mutation that predisposes someone to melanoma choroid is called BAP1. People with this mutation have a significantly increased risk of developing the disease, even if they don't have any family history of it.
There are a few symptoms of melanoma choroid which include:
1. A change in the color of your iris - this may be a sign that there is a growth or tumor on the choroid.
2. Blurry vision - this can be caused by the tumor growing and pressing on the retina.
3. Flashing lights or shadows in your vision - this can also be caused by thegrowth of the tumor pressing on the retina.
4. Pain in or around the eye - as the tumor grows, it can put pressure on nearby nerves and blood vessels, causing pain.
If you have been diagnosed with melanoma choroid, your treatment will be tailored to your individual situation. The main goal of treatment is to remove the tumor and prevent the cancer from coming back. Treatment options for melanoma choroid include surgery, radiation therapy, and chemotherapy.
Surgery is the most common treatment for melanoma choroid. The type of surgery depends on the size and location of the tumor. In some cases, the entire eye may need to be removed. Radiation therapy may also be used in conjunction with surgery or as a standalone treatment option.
Chemotherapy is typically not used to treat melanoma choroid because the cancer is very sensitive to this type of treatment. However, it may be an option for people who are not candidates for surgery or radiation therapy.
The side effects of treatment for melanoma choroid can vary depending on the type of treatment you receive. Surgery can cause vision problems, including blindness. Radiation therapy can cause fatigue, skin irritation, and hair loss. Chemotherapy can cause nausea, vomiting, hair loss, and low blood counts.
The best way to prevent melanoma choroid is to avoid exposure to ultraviolet (UV) radiation. UV radiation is a known risk factor for the development of melanoma
There are a few ways you can protect yourself from UV radiation:
-Wear sunscreen with an SPF of 30 or higher every day, even when it’s cloudy.
-Wear protective clothing, such as long-sleeved shirts and pants, when you’re outside.
-Stay in the shade as much as possible, especially between 10am and 4pm when the sun’s rays are the strongest.
If you have a family history of melanoma or if you’ve been diagnosed with another type of skin cancer, you may be at an increased risk for developing melanoma choroid. Talk to your doctor about ways you can further reduce your risk.
Prognosis for melanoma choroid is quite good if the cancer is detected early. The five-year survival rate is about 95 percent for people with this type of cancer. However, the survival rate drops to 50 percent for people who are diagnosed at a later stage. Treatment for melanoma choroid usually involves surgery to remove the cancerous tissue. In some cases, radiation therapy or chemotherapy may be recommended.
Melanoma Choroid is a rare eye cancer but one that should not be overlooked. It is important to be aware of the symptoms so you can catch it early and seek the right treatment. With proper diagnosis and treatment, survival rates are high. With awareness and understanding, we can work together to reduce the risk of developing this devastating disease.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation